Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Current Treatment Options in Oncology
|
August 13, 2016
Sequencing of New and Old Therapies for Metastatic Melanoma
Megan Ratterman, Sigrun Hallmeyer, Jon Richards
Cureus
|
February 6, 2016
High-Dose Radiation as a Dramatic, Immunological Primer in Locally Advanced Melanoma
Majid Mohiuddin, Harold Park, Sigrun Hallmeyer, et al.
AJP Reports
|
March 4, 2017
Management of Breast Cancer during Pregnancy: Are We Compliant with Current Guidelines?
Victoria Shlensky, Sigrun Hallmeyer, Lourdes Juarez, et al.
Biology Methods & Protocols
|
March 6, 2023
Characteristics of patients with hematologic malignancies without seroconversion post-COVID-19 third vaccine dosing
Sigrun Hallmeyer, Michael A Thompson, Veronica Fitzpatrick, et al.
Healthcare (Basel, Switzerland)
|
February 25, 2022
A Prospective, Longitudinal Evaluation of SARS-CoV-2 COVID-19 Exposure, Use of Protective Equipment and Social Distancing in a Group of Community Physicians
Eli D Ehrenpreis, Sigrun Hallmeyer, David H Kruchko, et al.
Journal of Patient-Centered Research and Reviews
|
August 8, 2022
Real-World Third COVID-19 Vaccine Dosing and Antibody Response in Patients With Hematologic Malignancies
Michael A Thompson, Sigrun Hallmeyer, Veronica E Fitzpatrick, et al.
Cancer Immunology, Immunotherapy : CII
|
November 12, 2005
Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146-154 peptide
Supriya Perambakam, Sigrun Hallmeyer, Samarth Reddy, et al.
Cancer Medicine
|
April 28, 2016
Real-world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the IMAGE study
Mark R Middleton, Stéphane Dalle, Joel Claveau, et al.
Journal for Immunotherapy of Cancer
|
December 23, 2022
Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study
Brendan D Curti, Jon Richards, John R Hyngstrom, et al.
Head & Neck
|
July 14, 2016
Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma
Robert H I Andtbacka, Sanjiv S Agarwala, David W Ollila, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Current Treatment Options in Oncology
|
August 13, 2016
Sequencing of New and Old Therapies for Metastatic Melanoma
Megan Ratterman, Sigrun Hallmeyer, Jon Richards
Cureus
|
February 6, 2016
High-Dose Radiation as a Dramatic, Immunological Primer in Locally Advanced Melanoma
Majid Mohiuddin, Harold Park, Sigrun Hallmeyer, et al.
AJP Reports
|
March 4, 2017
Management of Breast Cancer during Pregnancy: Are We Compliant with Current Guidelines?
Victoria Shlensky, Sigrun Hallmeyer, Lourdes Juarez, et al.
Biology Methods & Protocols
|
March 6, 2023
Characteristics of patients with hematologic malignancies without seroconversion post-COVID-19 third vaccine dosing
Sigrun Hallmeyer, Michael A Thompson, Veronica Fitzpatrick, et al.
Healthcare (Basel, Switzerland)
|
February 25, 2022
A Prospective, Longitudinal Evaluation of SARS-CoV-2 COVID-19 Exposure, Use of Protective Equipment and Social Distancing in a Group of Community Physicians
Eli D Ehrenpreis, Sigrun Hallmeyer, David H Kruchko, et al.
Journal of Patient-Centered Research and Reviews
|
August 8, 2022
Real-World Third COVID-19 Vaccine Dosing and Antibody Response in Patients With Hematologic Malignancies
Michael A Thompson, Sigrun Hallmeyer, Veronica E Fitzpatrick, et al.
Cancer Immunology, Immunotherapy : CII
|
November 12, 2005
Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146-154 peptide
Supriya Perambakam, Sigrun Hallmeyer, Samarth Reddy, et al.
Cancer Medicine
|
April 28, 2016
Real-world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the IMAGE study
Mark R Middleton, Stéphane Dalle, Joel Claveau, et al.
Journal for Immunotherapy of Cancer
|
December 23, 2022
Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study
Brendan D Curti, Jon Richards, John R Hyngstrom, et al.
Head & Neck
|
July 14, 2016
Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma
Robert H I Andtbacka, Sanjiv S Agarwala, David W Ollila, et al.
Page
of 3